PerpEquitiesEquity
Is Ecolab (ECL) tradable as a perp? Not yet
Ecolab provides water, hygiene, and infection prevention solutions across water treatment, institutional cleaning, pest elimination, and life sciences segments.
Price chart
Interactive TradingView chart
TradingView symbol NYSE:ECL
Loads TradingView's third-party widget (about 1 MB) on demand.
Auto: underlying reference priceOpen in TradingView
Company data
Company fundamentals
Updated 1h ago
Company data
Company fundamentals
Market cap
$75.8B
Updated 1h ago
Revenue
$16.8B
Trailing 12 months
Revenue growth
+11%
Next fiscal year
Profit margin
+12.6%
P/E
35.9
Peer P/E 5.4
Free cash flow
$1.9B
Trailing 12 months
More metrics
Net income
$2.1B
Trailing 12 months
P/S
4.5
Peer P/E
5.4
Similar listed perps
Revenue estimate
$17.9B
Next fiscal year
Earnings
2026-10-27
Revenue est. $4.7B · Updated 1h ago
Dividend
$0.73
2026-09-15
Fundamental detail
Annual + quarterlyLatest revenue$16.1B
Net margin+12.9%
Free cash flow$1.9B
Net debt$8.8B
PeriodRevenueGrowthNet incomeFCF
2020$11.8B-6%-$1.2B$1.4B
2021$12.7B+8%$1.1B$1.4B
2022$14.2B+11%$1.1B$1.1B
2023$15.3B+8%$1.4B$1.6B
2024$15.7B+3%$2.1B$1.8B
2025$16.1B+2%$2.1B$1.9B
PeriodGross marginOperating marginNet marginROEROA
2020+41.5%+14.5%-10.2%-19.5%-6.6%
2021+41.0%+13.2%+8.9%+15.6%+5.3%
2022+38.2%+11.3%+7.7%+15.1%+5.1%
2023+40.3%+14.1%+9.0%+17.1%+6.3%
2024+43.5%+16.6%+13.4%+24.1%+9.4%
2025+44.5%+18.1%+12.9%+21.2%+8.4%
PeriodCashDebtNet debtCurrent ratio
2020$1.3B$7.1B$5.9B1.75
2021$359.9M$9.2B$8.8B1.32
2022$598.6M$9B$8.4B1.30
2023$919.5M$8.7B$7.8B1.30
2024$1.3B$8.3B$7B1.26
2025$646.2M$9.4B$8.8B1.08
PeriodMarket capEnterprise valueP/SP/E
2020$62.1B$67.9B5.3-51.5
2021$67.2B$76B5.359.4
2022$41.5B$49.9B2.938.0
2023$56.5B$64.3B3.741.2
2024$66.6B$73.6B4.231.5
2025$74.4B$83.2B4.635.8
PeriodRevenueGrowthNet incomeFCF
Q3 2024$4B+1%$736.5M$550.3M
Q4 2024$4B+2%$472.9M$407M
Q1 2025$3.7B-2%$402.5M$131.5M
Q2 2025$4B+1%$524.2M$485.1M
Q3 2025$4.2B+4%$585M$529.7M
Q4 2025$4.2B+5%$563.9M$758M
Q1 2026$4.1B+10%$432.6M$97.4M
Q2 2026$4.4B+10%$534.9M$489.4M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+43.4%+17.7%+18.4%+8.6%+3.3%
Q4 2024+43.4%+17.1%+11.8%+5.4%+2.1%
Q1 2025+44.3%+15.9%+10.9%+4.5%+1.8%
Q2 2025+44.8%+17.6%+13.0%+5.6%+2.2%
Q3 2025+44.8%+18.3%+14.0%+6.0%+2.4%
Q4 2025+44.0%+18.7%+13.4%+5.8%+2.3%
Q1 2026+43.6%+15.3%+10.6%+4.3%+1.7%
Q2 2026+44.1%+17.2%+12.1%+5.3%+1.8%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$1.3B$8.3B$7B1.30
Q4 2024$1.3B$8.3B$7B1.26
Q1 2025$1.2B$8.4B$7.2B1.32
Q2 2025$1.9B$9B$7B1.44
Q3 2025$2B$9.4B$7.5B1.70
Q4 2025$646.2M$9.4B$8.8B1.08
Q1 2026$519.8M$9.3B$8.7B0.99
Q2 2026$5.1B$13.8B$8.6B1.84
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$72.4B$79.5B18.124.6
Q4 2024$66.9B$74B16.735.1
Q1 2025$71.8B$79B19.444.6
Q2 2025$76.4B$83.4B19.036.4
Q3 2025$77.6B$85.1B18.633.2
Q4 2025$74.2B$82.9B17.732.8
Q1 2026$75B$83.8B18.443.5
Q2 2026$78.4B$87B17.736.5
Refreshed 1h ago
Charts: revenue, profit, cash flow & valuation
CashDebt
Gross marginOperating marginNet margin
P/EP/S
CashDebt
Gross marginOperating marginNet margin
P/EP/S
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6DateEPS estimateRevenue estimateGrowthAnalysts
FY 20268.15$17.9B+11%13
FY 20279.39$19.3B+20%13
FY 202810.71$20.4B+27%4
Q1 20271.92$4.5B+10%5
Q2 20272.35$4.8B+10%5
Q3 20272.56$5B+20%5
Company events
62026-10-27EarningsActual - / Estimate 2.18-
2026-09-15Dividend$0.73-
2026-07-28EarningsActual 2.09 / Estimate 2.08Beat
2026-06-16Dividend$0.73-
2026-04-28EarningsActual 1.7 / Estimate 1.7In line
2026-03-17Dividend$0.73-
Peer comparison
Similar listed perpsRevenue mix
PendingSegment data is not available yet.
Analysts
PendingNo analyst data available yet.
Ownership
ECL-PERPOwnership data is being populated.
Filings
PendingNo filings available yet.
Transcripts
PendingNo transcripts available yet.
Latest updates
PendingNo recent updates available.
Analyst track record
How the analysts covering ECL have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 144 | 371 |
| Analysts | 25 | 33 |
| Buy / hold / sell | 120 / 24 / 0 | 265 / 104 / 2 |
| Upgrades / downgrades / initiations | 8 / 1 / 1 | 20 / 5 / 6 |
| Price targets hit / missed | 5 / 116 (4%) | 111 / 213 (34%) |
| Avg. return after a rating (TipRanks) | -13.1% | -2.5% |
| Best / worst call | +4.5% / -24.5% | +50.9% / -24.5% |
After buy calls on this stock: median 21-day move +1.9% vs S&P 500 -1.1% (n = 265)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- Manav PatnaikBarclays92% hit rate on this stock · 25 targets measuredBuytarget $300Aug 26, 2026
- Ashish SabadraRBC Capital85% hit rate on this stock · 27 targets measuredBuytarget $337Aug 18, 2026
- Shlomo RosenbaumStifel Nicolaus63% hit rate on this stock · 8 targets measuredBuytarget $337Jul 29, 2026
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Sep 15, 2026 | Jason Haas CFAWells Fargo | HoldReiterated | $295 | article ↗ |
| Aug 26, 2026 | Manav PatnaikBarclays | BuyMaintained | $300 | article ↗ |
| Aug 18, 2026 | Ashish SabadraRBC Capital | BuyMaintained | $337 | |
| Aug 19, 2026 | Matthew DeYoeBank of America Securities | BuyMaintained | – | article ↗ |
| Aug 18, 2026 | Ashish SabadraRBC Capital | BuyMaintained | $337 | article ↗ |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data via FMP · computed Sep 18, 2026 · 144 ratings